A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis

Enhanced ceramide glycosylation catalyzed by glucosylceramide synthase (GCS) limits therapeutic efficiencies of antineoplastic agents including doxorubicin in drug-resistant cancer cells. Aimed to determine the role of GCS in tumor response to chemotherapy, a new mixed-backbone oligonucleotide (MBO-...

Descripción completa

Detalles Bibliográficos
Autores principales: Patwardhan, Gauri A., Zhang, Qian-Jin, Yin, Dongmei, Gupta, Vineet, Bao, Jianxiong, Senkal, Can E., Ogretmen, Besim, Cabot, Myles C., Shah, Girish V., Sylvester, Paul W., Jazwinski, S. Michal, Liu, Yong-Yu
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735002/
https://www.ncbi.nlm.nih.gov/pubmed/19742320
http://dx.doi.org/10.1371/journal.pone.0006938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735002/
https://www.ncbi.nlm.nih.gov/pubmed/19742320
http://dx.doi.org/10.1371/journal.pone.0006938

Ejemplares similares